Meeting to be held on March 24 and on March 26 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on IMRX: Immuneering’s Strategic Advancements and Financial Strength Bolster Buy Rating Immuneering reports Q4 EPS (58c), consensus (44c) Immuneering appoints Matushansky as Chief Medical Officer Immuneering management to meet with Oppenheimer Immuneering Corp. Class A (IMRX) Q4 Earnings Cheat Sheet Disclaimer & DisclosureReport an Issue
